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Abstract 
Purpose – Infant formula is the sole nutrition and food source for many infants. Information on the 
free amino acid (FAA) content of formulas, particularly those that are protein hydrolysate based, is 
limited, despite emerging evidence for the role of FAAs in regulating eating behaviour. The purpose of 
this paper is to measure levels of essential, semi-essential, and nonessential FAAs in commercially 
available infant formulas to provide a foundation for future research examining the inﬂuence of FAAs 
on infant development. 
Design/methodology/approach – Using an automatic amino acid analyzer, we measured the 
concentrations of FAAs in four types of formula: two cow milk (CMF); three soy protein (SPF); and 
three protein hydrolysate (PHF), one of which was a partial hydrolysate (pPHF) and two of which were 
extensive hydrolysate (ePHF). 
Findings – It was found that the amount and number of FAAs varied signiﬁcantly across formula 
types: for CMF, total FAAs ranged from 523-864 mmol/L, with taurine being the most prominent; SPF, 
1933-2450, methionine; pPHF, 2329, taurine; and ePHF, 80375-85445, leucine. ePHF had the highest 
levels and the most diversiﬁed proﬁles of FAAs. 
Research limitations/implications – Striking discrepancies exist for FAA proﬁles of infant 
formulas. Comparison of these data to published psychophysical data on the taste qualities of 
individual FAAs provides insights into the unique ﬂavor proﬁles of infant formulas. Overall, the data 
from this study provide a necessary foundation for future research examining the inﬂuence of FAAs in 
formulas on infant growth and development. 
Originality/value – Published data on the FAA content of PHF is limited, despite their increased 
availability and use. This research is the ﬁrst to report the FAA content of partial and extensive PHF, 
and to compare these values to CMF and SPF. 
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1. Introduction 
During early life, the protein in human milk and infant formulas supports infant growth, 
immune function, and behavioral development by supplying nitrogen and essential and 
semi-essential amino acids (Dewey et al., 1996). Because of rapid rates of growth during 
infancy, and because the metabolic pathways needed to create semi-essential amino 
acids are not fully developed (Imura and Okada, 1998), the protein content and levels of 
the nine essential and four semi-essential amino acids for infant formulas are speciﬁed 
by the World Health Organization (WHO) (FAO/WHO, 2007). 
Current formulas for term infants vary in protein source and/or degree of protein 
hydrolysis (see American Academy of Pediatrics Committee on Nutrition (2000), 
Koletzko et al. (2005) for review). Cow milk formula (CMF), which accounted for 76 percent 
of all US infant formula sales in 2000 (ERS/USDA, 2005), has a protein source that 
includes casein or whey proteins. Soy protein formula (SPF) contains soy protein isolate, 
usually intact but sometimes partially digested. Less prevalent is extensive protein 
hydrolysate formula (ePHF), which is typically fed to infants who have cow milk protein 
allergy or intolerance to intact protein (American Academy of Pediatrics Committee on 
Nutrition, 2000). The milk proteins in ePHF are treated with enzymes to break down the 
protein structure to reduce allergenicity and facilitate digestion (Cook and Sarett, 1982; 
Lee, 1992). Partial protein hydrolysate formulas (pPHF) are also available, containing a 
combination of intact and partially digested proteins. 
Differences in protein source, processing, and degree of hydrolysis create large 
differences in the non-protein nitrogen content of formulas (Cook and Sarett, 1982; Lee, 
1992), which includes free amino acids (FAAs), urea, small peptides, and any other 
nitrogen-containing compounds that are not bound to intact proteins (Rudloff and Kunz, 
1997). Despite the signiﬁcant contribution of non-protein nitrogen to the total nitrogen 
content of infant formulas (Donovan and Lonnerdal, 1989), WHO standards do not specify 
FAA content in infant formulas (FAO/WHO, 2007; Koletzko et al., 2005). Further, the exact 
levels of FAAs present in infant formulas are not typically provided on manufacturers’ 
web sites and research documenting the FAA content of CMF and SPF is limited 
(Agostoni et al., 2000; Caja et al., 2006; Chuang et al., 2005; Ferreira, 2003; Yeung et al., 2006; 
Zunin and Evangelisti, 1999). Additionally, no studies have described the FAA content of 
pPHFs or ePHFs. 
The paucity of information on the FAAs in infant formulas, particularly PHF, is 
signiﬁcant for two reasons. First, the consumption of both pPHF and ePHF has been 
on the rise among healthy formula-fed infants. Second, formula-fed infants are not 
a homogeneous group. For example, we recently reported that, when compared to 
breastfed infants, CMF-fed infants weight gain was accelerated, whereas the weight 
gain of ePHF-fed infants was normative (Mennella et al., 2011). The more normative 
growth may be attributed to the ﬁnding that ePHF-fed infants consumed less formula 
to satiation during monthly laboratory-based, infant-led feeding sessions than did 
CMF-fed infants. 
Based on these data, we hypothesize that higher levels of FAAs in ePHF compared 
to CMF contribute, in part, to these differences in satiation and growth. However, this 
hypothesis, and others like it, cannot be tested until data on the exact levels of FAA in 
formulas are available. To this end, we measured levels of essential, semi-essential, and 
nonessential FAAs in commercially available infant formulas to provide a foundation 
for future research examining the inﬂuence of FAAs on infant development. 
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2. Materials and methods 
A representative sample of the formulas most commonly consumed by US infants 
(ERS/USDA, 2005) was selected at random from a supermarket in Philadelphia (PA, 
USA). To this end, eight different formulas were studied: two CMF, three SPF, one pPHF, 
and two ePHF (Table I). We chose the liquid-ready-to-feed versions, rather than 
powdered or liquid concentrate, to minimize errors in preparation (FAO/WHO, 2007). 
We also analyzed two powdered versions (CMF-1, PHF-1) to compare powdered versus 
liquid-ready-to-feed formulations. 
For each formula, 20 mL was deproteinized with 10 mL sulfosalicylic acid (6 percent), 
mixed on vortex type mixer, and centrifuged immediately (48C, 15 min, 1,200 g). The 
supernatant was puriﬁed with a 0.45 mm ﬁlter, and molecules . 10 kDa were removed 
with an Amiconw Ultra centrifugal ﬁlter (Millipore, Tokyo, Japan). We measured amino 
acid concentrations with an automatic amino acid analyzer (model L-8900; Hitachi, 
Tokyo, Japan) that separates amino acids by cation-exchange chromatography. The 
analyzer system has a high-reproducibility retention time with coefﬁcient of variation 
(CV) 0.3 percent (Arg), peak area with CV 1.0 percent (Gly, His), and limit of detection 
(LOD) of 3 pmol (signal-to-noise ratio (S:N) ¼ 2; Asp). Reproducibility was veriﬁed by 
measurements of standard preparations. 
Each amino acid was detected spectrophotometrically after postcolumn reaction 
with ninhydrin reagent (Noguchi et al., 2006). We diluted SPF-3 (six-fold) and ePHF-1 
(7.5-fold) because initial analyses revealed that amino acid levels were out of range. 
Samples were analyzed in duplicate; data were adjusted for dilution factor (if 
applicable) and are presented as average micromoles per liter. Amino acid standards 
were intercalated with each sample to ensure reproducibility $ 98 percent or CV , 2 
percent. LOD varied from 2 to 10 mmol/L and was speciﬁc to each amino acid. Values 
, three-fold the S:N were considered to be in the LOD. 
3. Results and discussion 
Table I presents FAA levels for each formula. ePHF had the highest levels of FAAs, 
averaging 120-fold higher than CMF, 39-fold higher than SPF, and 36-fold higher than 
pPHF. Many FAAs were undetectable or present at the LOD (i.e. present in trace 
amounts), meaning these amino acids are present only within intact proteins in these 
formulas. In contrast, all FAAs were detected in ePHF (with the exception of glutamine 
in ePHF-1). 
ePHF was most abundant in free leucine (14-15 percent), glutamic acid (9-10 percent), 
lysine (8-10 percent), and valine (9 percent), which accounted for approximately 
42 percent of total FAA content. ePHF also differed within formula type: ePHF-2 
contained more FAAs than did ePHF-1 (85,445 versus 80,375 mmol/L), almost two-fold 
the proline of ePHF-1, and a small amount of glutamine, versus none in ePHF-1. Levels of 
FAAs were substantially lower in pPHF than in ePHF, and some amino acids (isoleucine, 
leucine, valine, cystine, glutamine) found at high levels in ePHF were not detectable 
in pPHF. 
Overall, the total FAA content for SPF, ranging from 1,933 to 2,450 mmol/L, was 
lower than for ePHF. Only seven to 12 of the FAAs found in SPF exceeded the LOD in 
free form. SPF was most abundant in methionine, which contributed 65-75 percent of 
FAA content. Taurine was the next most abundant, contributing 21-22 percent of FAA 
content. The other FAAs each contributed ,2 percent of the FAA content. 
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Table I. 
FAA content (mmol/L) 
of different types of infant 
formulas 
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The total FAA content for CMF (523-864 mmol/L) was considerably lower than for SPF 
and PHF. While the most abundant FAAs in CMF were taurine (61-74 percent) and 
glutamic acid (13-17 percent), the two CMFs differed most in proline content: 7 percent in 
CMF-1 versus none in CMF-2. CMF-1 also contained 1.7-fold the amount of FAAs found 
in CMF-2. 
Comparison of powdered and liquid-ready-to-feed versions of CMF-1 and ePHF-1 
showed little variation (data not shown). For example, CMF-1 as powder contained 
125 mmol/L free glutamate, versus 109 mmol/L in the liquid-ready-to-feed version. 
Similarly, ePHF-1 as powder contained 7,238 mmol/L free glutamate, versus 7,472 mmol/L 
in the liquid-ready-to-feed version. The CV was 1.7 between the CMF-1 formulations and 
0.8 between the ePHF-1 formulations. 
It remains unknown why the levels of FAAs are so high in some formulas and what 
impact FAA content may have on infant development (see commentary in Hernell and 
Lonnerdal (2003)). In the present study, we found that total levels of FAAs in ePHF were 
substantially higher than in human breast milk (3,019 mmol/L (Agostoni et al., 2000)). In 
contrast, FAA levels in CMF or SPF were two- to ﬁve-fold lower than in breast milk 
(Agostoni et al., 2000). Several studies have documented that infants who feed ePHF 
have much higher serum FAAs than do infants fed breast milk or non-hydrolyzed 
formulas (Giovannini et al., 1994; Hernell and Lonnerdal, 2003; Rigo et al., 1995), the 
consequence of which is still unclear. The effects, if any, that the relative and absolute 
levels of FAAs in breast milk or formulas have on the establishment of long-term ﬂavor 
and food preferences and understanding the impact of their effects on infant feeding, 
growth, and development should be a priority for future research. 
Infants can detect ﬂavor differences among various types of formulas and grow to 
prefer the brand that they experience early in life (Mennella and Beauchamp, 2005). 
Because these ﬂavors are complex, psychophysical data for formulas will not provide 
information on how their varying FAA levels contribute to overall ﬂavor. As a 
preliminary examination of the potential relation between formula feeding and ﬂavor 
preferences, we compared published psychophysical data on the taste qualities of 
individual FAAs (Schiffman et al., 1979; Schiffman and Dackis, 1975) with the FAA 
proﬁles of individual formulas from the present study (Table II). For each formula 
under study, FAAs that comprised greater than 1 percent of the total FAA content 
were ranked based on the amount present in the formula (1 ¼ highest amount). 
By combining the ﬁndings of the present study with the information provided by 
Schiffman and Dackis (1975), one may predict the impact FAA content on the ﬂavor of 
infant formula. For example, sensory panel work has shown that SPF tastes more sweet, 
sour, and bitter than CMF (Cook and Sarett, 1982). SPF is enriched with both taurine and 
methionine, as reﬂected in the relative abundance of these two amino acids in the soy 
formulas analyzed in the present study. Methionine has been reported to taste 
“repulsive, metallic, minerally [. . .] bitter” (Schiffman and Dackis, 1975), which is may be 
one contributor to the bitterness of SPF. Sweet ﬂavors of SPF may come from, in part, the 
relatively higher levels of taurine (Schiffman and Dackis, 1975). 
The savory, sour, and bitter ﬂavors of ePHF may be attributable to the high levels of 
glutamic acid (meaty or savory), valine (slightly bitter with sour and sweet aspects), and 
lysine (salty and bitter) (Schiffman and Dackis, 1975). Additionally, differences in FAA 
proﬁles between ePHFs may underlie reports that ePHF-2 is sweeter than ePHF-1 
(Mennella and Beauchamp, 2005): ePHF-2 contains almost twice as much proline, 
FAA content in 
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Table II. 
Psychophysical taste 
qualities of FAAsa and 
FAA rankingb according 
to amount detected in a 
variety of infant formulas 
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a sweet tasting amino acid, as ePHF-1. However, it is also important to note that the 
difference in sweetness may also be due to differences in carbohydrate source, as ePHF-2 
contains sucrose and corn maltodextrin while ePHF-1 contains corn syrup solids 
and modiﬁed corn starches. Overall, the higher levels of FAAs in ePHF may create a 
more powerful ﬂavor experience compared with other formula types and thus underlie 
strong and distinctive bitter, sour, and savory taste characteristics of ePHF. 
4. Conclusions 
Striking differences exist both among and within different types of infant formulas 
in total amounts and numbers of FAAs. Differences between CMF and SPF centered 
on taurine and methionine, as previously reported (Agostoni et al., 2000), whereas 
differences among non-hydrolyzed (CMF, SPF), partially hydrolyzed (pPHF), and 
extensively hydrolyzed (ePHF) formulas were considerable. These ﬁndings 
provide insights into the unique ﬂavor proﬁles of infant formulas and a foundation 
for examining the mechanisms underlying the differential impact of infant formulas on 
infant satiation and growth. 
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